![Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever](https://www.mdpi.com/vaccines/vaccines-09-00483/article_deploy/html/images/vaccines-09-00483-g001.png)
Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
![Current perspectives on conventional and novel vaccines against peste des petits ruminants | SpringerLink Current perspectives on conventional and novel vaccines against peste des petits ruminants | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11259-014-9618-x/MediaObjects/11259_2014_9618_Fig3_HTML.gif)
Current perspectives on conventional and novel vaccines against peste des petits ruminants | SpringerLink
![Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats | npj Vaccines Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats | npj Vaccines](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41541-019-0138-0/MediaObjects/41541_2019_138_Fig1_HTML.png)
Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats | npj Vaccines
![Table 1 from Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar Table 1 from Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/791aecf7ca8524c29d56736d7ef04703c0d36f5b/36-Table1-1.png)
Table 1 from Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar
![Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever](https://www.mdpi.com/vaccines/vaccines-09-00483/article_deploy/html/images/vaccines-09-00483-g004.png)
Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
![The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse model of congenital neosporosis - ScienceDirect The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse model of congenital neosporosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0001706X19300993-ga1.jpg)
The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse model of congenital neosporosis - ScienceDirect
OBJECTIVES INTRODUCTION DIVA STRATEGY AGAINST CSFV REFERENCES CONCLUSIONS DIVA VACCINES APPLICATIONS DIVA VACCINES AGAINST CLASS
The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse mod
![PDF] Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar PDF] Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/62d9c63b66492b27686c5b44df6162d5937f743e/46-Figure2-1.png)
PDF] Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar
![Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design - ScienceDirect Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0147957113000143-gr3.jpg)
Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design - ScienceDirect
![Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. - Abstract - Europe PMC Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9354547/bin/fcimb-12-954811-g007.jpg)
Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. - Abstract - Europe PMC
![DIVA strategy for SARS-CoV-2 serological testing. The usage of a DIVA... | Download Scientific Diagram DIVA strategy for SARS-CoV-2 serological testing. The usage of a DIVA... | Download Scientific Diagram](https://www.researchgate.net/publication/353643131/figure/fig1/AS:1052356078755842@1627912649945/DIVA-strategy-for-SARS-CoV-2-serological-testing-The-usage-of-a-DIVA-assay-kit-to.png)
DIVA strategy for SARS-CoV-2 serological testing. The usage of a DIVA... | Download Scientific Diagram
![Vaccine development against Schmallenberg virus: from classical inactivated to modified-live to scaffold particle vaccines | One Health Outlook | Full Text Vaccine development against Schmallenberg virus: from classical inactivated to modified-live to scaffold particle vaccines | One Health Outlook | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42522-022-00069-8/MediaObjects/42522_2022_69_Fig1_HTML.png)